Literature DB >> 18516317

The chick embryo chorioallantoic membrane in the study of tumor angiogenesis.

D Ribatti1.   

Abstract

The chick embryo chorioallantoic membrane (CAM) is commonly used as an experimental in vivo assay to study both angiogenesis and antiangiogenesis in response to tissues, cells or soluble factors. This article summarizes literature data about the use of the CAM in the study of tumor angiogenesis and particularly our experimental data concerning the study of angiogenesis in multiple myeloma and in neuroblastoma.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18516317

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN： 1220-0522            Impact factor:   1.033


  23 in total

1.  Mapping the extracellular and membrane proteome associated with the vasculature and the stroma in the embryo.

Authors:  Fabienne Soulet; Witold W Kilarski; Florence Roux-Dalvai; John M J Herbert; Izabela Sacewicz; Emmanuelle Mouton-Barbosa; Roy Bicknell; Patricia Lalor; Bernard Monsarrat; Andreas Bikfalvi
Journal:  Mol Cell Proteomics       Date:  2013-05-14       Impact factor: 5.911

2.  Antiangiogenic activity of PLGA-Lupeol implants for potential intravitreal applications.

Authors:  Daniel Crístian Ferreira Soares; Diogo Coelho de Paula Oliveira; Luciola Silva Barcelos; Alan Sales Barbosa; Lorena Carla Vieira; Danyelle M Townsend; Domenico Rubello; André Luis Branco de Barros; Lucienir Pains Duarte; Armando Silva-Cunha
Journal:  Biomed Pharmacother       Date:  2017-05-27       Impact factor: 6.529

Review 3.  Following up tumour angiogenesis: from the basic laboratory to the clinic.

Authors:  José L Orgaz; Beatriz Martínez-Poveda; Nuria I Fernández-García; Benilde Jiménez
Journal:  Clin Transl Oncol       Date:  2008-08       Impact factor: 3.405

4.  Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell Carcinoma.

Authors:  Tram Anh Tran; Hon Sing Leong; Andrea Pavia-Jimenez; Slavic Fedyshyn; Juan Yang; Blanka Kucejova; Sharanya Sivanand; Patrick Spence; Xian-Jin Xie; Samuel Peña-Llopis; Nicholas Power; James Brugarolas
Journal:  Mol Cell Biol       Date:  2016-06-15       Impact factor: 4.272

5.  Effects of ursolic and oleanolic on SK‑MEL‑2 melanoma cells: In vitro and in vivo assays.

Authors:  Angela Caunii; Camelia Oprean; Mirabela Cristea; Alexandra Ivan; Corina Danciu; Calin Tatu; Virgil Paunescu; Daniela Marti; George Tzanakakis; Demetrios A Spandidos; Aristides Tsatsakis; Razvan Susan; Codruta Soica; Stefana Avram; Cristina Dehelean
Journal:  Int J Oncol       Date:  2017-10-16       Impact factor: 5.650

6.  Optimising the chick chorioallantoic membrane xenograft model of neuroblastoma for drug delivery.

Authors:  Rasha Swadi; Grace Mather; Barry L Pizer; Paul D Losty; Violaine See; Diana Moss
Journal:  BMC Cancer       Date:  2018-01-04       Impact factor: 4.430

7.  Hypoxia-induced mobilization of NHE6 to the plasma membrane triggers endosome hyperacidification and chemoresistance.

Authors:  Fabrice Lucien; Pierre-Paul Pelletier; Roxane R Lavoie; Jean-Michel Lacroix; Sébastien Roy; Jean-Luc Parent; Dominique Arsenault; Kelly Harper; Claire M Dubois
Journal:  Nat Commun       Date:  2017-06-21       Impact factor: 14.919

8.  Standardization of A375 human melanoma models on chicken embryo chorioallantoic membrane and Balb/c nude mice.

Authors:  Stefana Avram; Dorina-Elena Coricovac; Ioana Zinuca Pavel; Iulia Pinzaru; Roxana Ghiulai; Flavia Baderca; Codruta Soica; Danina Muntean; Daciana E Branisteanu; Demetrios A Spandidos; Aristides M Tsatsakis; Cristina Adriana Dehelean
Journal:  Oncol Rep       Date:  2017-05-22       Impact factor: 3.906

9.  Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis.

Authors:  Isabel Heidegger; Johann Kern; Philipp Ofer; Helmut Klocker; Petra Massoner
Journal:  Oncotarget       Date:  2014-05-15

10.  Lectin-like oxidized LDL receptor-1 is an enhancer of tumor angiogenesis in human prostate cancer cells.

Authors:  Iván González-Chavarría; Rita P Cerro; Natalie P Parra; Felipe A Sandoval; Felipe A Zuñiga; Valeska A Omazábal; Liliana I Lamperti; Silvana P Jiménez; Edelmira A Fernandez; Nicolas A Gutiérrez; Federico S Rodriguez; Sergio A Onate; Oliberto Sánchez; Juan C Vera; Jorge R Toledo
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.